# Associations of Multimarkers of Metabolic Malnutrition and Inflammation With All‐Cause Mortality and Their Interplay With Thyroid Function

**Authors:** Setor K. Kunutsor, Reyhaneh Rikhtehgaran, Yanning Xu, Margery A. Connelly, Irina Shalaurova, Layal Chaker, Stephan J. L. Bakker, Robin P. F. Dullaart

PMC · DOI: 10.1002/edm2.70162 · Endocrinology, Diabetes & Metabolism · 2026-02-06

## TL;DR

A composite biomarker of metabolic malnutrition and inflammation is linked to higher mortality risk, and thyroid function does not affect this relationship.

## Contribution

The study shows that thyroid function does not modify the mortality risk associated with a metabolic vulnerability index in the general population.

## Key findings

- MVX, IVX, and MMX show graded dose–response relationships with all-cause mortality.
- Adjusting for thyroid function does not change the mortality risk estimates.
- Sex and thyroid hormone levels do not significantly modify the associations.

## Abstract

The metabolic vulnerability index (MVX)—a composite biomarker reflecting metabolic malnutrition and inflammation—has been linked to increased mortality risk in populations with cardiovascular disease. Thyroid function, a key regulator of metabolism and inflammation, may confound or modify this relationship, but evidence in the general population is limited.

To evaluate the interplay between MVX and its subcomponents (inflammation vulnerability index, IVX and metabolic malnutrition index, MMX), thyroid function, and mortality risk in the general population.

In the PREVEND prospective study, which included 5446 participants (mean age 54 years; 49.9% male), both MVX (estimated using six metabolites measured simultaneously through nuclear magnetic resonance spectroscopy) and thyroid function (FT3, FT4, TSH) were evaluated at baseline. Hazard ratios (HRs) with 95% confidence intervals (CIs) for all‐cause mortality were estimated.

During a median follow‐up of 14.1 years, 806 deaths were recorded. Spline analyses showed graded dose–response relationships of MVX, IVX and MMX with mortality risk. In separate analyses adjusted for several established risk factors, the HRs (95% CIs) of mortality were 1.28 (1.18–1.38), 1.23 (1.14–1.32) and 1.16 (1.07–1.25) per 1 standard deviation increment in MVX, IVX and MMX, respectively. The HRs remained consistent on further adjustment for FT3, FT4 and TSH. Sex as well as levels of FT3, FT4 and TSH did not significantly modify the associations.

The MVX and its subcomponents (IVX and MMX) are independently associated with all‐cause mortality, consistent with graded dose–response relationships. Thyroid function does not confound or modify these associations.

MVX, Thyroid Function and Mortality.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, HP (haptoglobin) [NCBI Gene 3240] {aka HP2ALPHA2, HPA1S}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, SERPINA3 (serpin family A member 3) [NCBI Gene 12] {aka AACT, ACT, GIG24, GIG25}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** MVX (MESH:D008659), NTIS (MESH:D005067), Chronic inflammation (MESH:D007249), dyslipidemia (MESH:D050171), endothelial dysfunction (MESH:D014652), Chronic Kidney Disease (MESH:D051436), thyroid (MESH:D013966), PREVEND (MESH:D007676), chronic obstructive pulmonary disease (MESH:D029424), protein-energy malnutrition (MESH:D011502), metabolic dysregulation (MESH:D021081), death (MESH:D003643), cardiovascular and renal disease (MESH:D002318), MMX (MESH:D044342), kidney or liver disease (MESH:D008107), heart failure (MESH:D006333), atherosclerosis (MESH:D050197), cardiometabolic abnormalities (MESH:D024821), insulin resistance (MESH:D007333), chronic (MESH:D002908), cancer (MESH:D009369), T2D (MESH:D003924), rheumatoid arthritis (MESH:D001172), immune dysregulation (OMIM:614878), thyroid autoimmunity (MESH:D013967), thyroid diseases (MESH:D013959)
- **Chemicals:** alcohol (MESH:D000438), triglycerides (MESH:D014280), cholesterol (MESH:D002784), isoleucine (MESH:D007532), EDTA (MESH:D004492), triiodothyronine (MESH:D014284), branched chain amino acids (MESH:D000597), citrate (MESH:D019343), FPG (-), levothyroxine (MESH:D013974), creatinine (MESH:D003404), leucine (MESH:D007930), glucose (MESH:D005947), lipid (MESH:D008055), valine (MESH:D014633), N-acetylglucosamine (MESH:D000117)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12880609/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12880609/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12880609/full.md

---
Source: https://tomesphere.com/paper/PMC12880609